Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Qingfei Runzao granules is a Traditional Chinese Medicine (TCM) formulation developed by the Affiliated Hospital of Liaoning University of Traditional Chinese Medicine. It is specifically designed for the treatment of post-infectious cough (PIC) in children, particularly those presenting with the 'dryness' syndrome pattern according to TCM theory. As a granule preparation, it consists of a multi-herb botanical formulation intended to clear the lungs and moisten dryness to relieve persistent coughing following respiratory infections. The drug is currently being evaluated in clinical studies to determine its clinical efficacy and identify dominant biological targets in comparison to other pediatric cough treatments like Xiaoer cough syrup.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Qingfei Runzao granules.